Glucotrack (GCTK) Free Cash Flow (2010 - 2025)

Glucotrack (GCTK) has 16 years of Free Cash Flow data on file, last reported at -$4.0 million in Q4 2025.

• Quarterly Free Cash Flow fell 13.06% year-over-year to -$4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15.3 million (down 21.77% YoY) and the FY2025 annual result came in at -$15.3 million, down 21.77% from the prior year.
• Free Cash Flow rose to -$4.0 million in Q4 2025, from -$4.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$608000.0 in Q3 2022 to a low of -$4.7 million in Q3 2025.
• A 5-year average of -$2.1 million and a median of -$1.6 million in 2023 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow soared 31.99% — and 2023, when it slumped 209.21%.
• Tracing GCTK's Free Cash Flow over 5 years: stood at -$977000.0 in 2021, then advanced by 4.09% to -$937000.0 in 2022, then slumped by 157.31% to -$2.4 million in 2023, then slumped by 45.13% to -$3.5 million in 2024, then dropped by 13.06% to -$4.0 million in 2025.
• The last three Free Cash Flow figures came in at -$4.0 million (Q4 2025), -$4.7 million (Q3 2025), and -$3.7 million (Q2 2025), per Business Quant data.